J.Jpn. Surg. Soc.. 123(1): 89-91, 2022
Proceedings of Special Sessions of Annual Congress
NOVEL COMBINATION IMMUNOTHERAPY AGAINST GASTROINTESTINAL CANCER
1) Department of Translational Research and Developmental Therapeutics against Cancer, Yamaguchi University School of Medicine, Ube, Japan Shoichi Hazama1), Koji Tamada2), Naoya Kato3), Michiie Sakamoto4), Hiroaki Nagano5) |
To read the PDF file you will need Adobe Reader installed on your computer.